{{Rsnum
|rsid=1602565
|Chromosome=11
|position=29140589
|Orientation=plus
|GMAF=0.1056
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 2.7 | 13.4 | 83.9
| HCB | 1.5 | 25.9 | 72.6
| JPT | 3.6 | 19.6 | 76.8
| YRI | 0.0 | 3.4 | 96.6
| ASW | 0.0 | 8.8 | 91.2
| CHB | 1.5 | 25.9 | 72.6
| CHD | 0.9 | 24.5 | 74.5
| GIH | 0.0 | 15.3 | 84.7
| LWK | 0.0 | 2.7 | 97.3
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 14.1 | 85.9
| TSI | 1.0 | 19.6 | 79.4
| HapMapRevision=28
}}

{{GWAS Summary
|SNP=rs1602565
|PubMedID=18677311
|Condition=Schizophrenia
|Gene=Intergenic
|Risk Allele=C
|pValue=3.00E-006
|OR=1.16
|95CI=
}}

{{PharmGKB
|RSID=rs1602565
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:18677311; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS Results: Identification of loci associated with schizophrenia by genome-wide association and follow-up (Initial Sample Size: 479 cases, 2,937 controls; Replication Sample Size: 6,666 cases, 9,897 controls; Risk Allele: rs1602565-C). This variant is associated with Schizophrenia.
|Drugs=
|Drug Classes=
|Diseases=Schizophrenia
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356548
}}

{{PMID|19911060|OA=1
}} Persistence criteria for susceptibility genes for schizophrenia: a discussion from an evolutionary viewpoint.

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1602565
|overall_frequency_n=15
|overall_frequency_d=126
|overall_frequency=0.119048
|n_genomes=10
|n_genomes_annotated=0
|n_haplomes=12
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
|n_web_uneval=10
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}